Clinical validation of a novel automated cell‐free DNA screening assay for trisomies 21, 13, and 18 in maternal plasma

OBJECTIVE: To evaluate clinical performance of a new automated cell‐free (cf)DNA assay in maternal plasma screening for trisomies 21, 18, and 13, and to determine fetal sex. METHOD: Maternal plasma samples from 1200 singleton pregnancies were analyzed with a new non–sequencing cfDNA method, which is...

Descripción completa

Detalles Bibliográficos
Autores principales: Ericsson, Olle, Ahola, Tarja, Dahl, Fredrik, Karlsson, Filip, Persson, Fredrik, Karlberg, Olof, Roos, Fredrik, Alftrén, Ida, Andersson, Björn, Barkenäs, Emelie, Boghos, Ani, Brandner, Birgit, Dahlberg, Jenny, Forsgren, Per‐Ola, Francois, Niels, Gousseva, Anna, Hakamali, Faizan, Janfalk‐Carlsson, Åsa, Johansson, Henrik, Lundgren, Johanna, Mohsenchian, Atefeh, Olausson, Linus, Olofsson, Simon, Qureshi, Atif, Skarpås, Björn, Svahn, Peter, Sävneby, Anna, Åström, Eva, Sahlberg, Anna, Fianu‐Jonasson, Aino, Gautier, Jérémie, Costa, Jean‐Marc, Jacobsson, Bo, Nicolaides, Kypros
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6899636/
https://www.ncbi.nlm.nih.gov/pubmed/31429096
http://dx.doi.org/10.1002/pd.5528

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6899636/
https://www.ncbi.nlm.nih.gov/pubmed/31429096
http://dx.doi.org/10.1002/pd.5528

Ejemplares similares